FDA Grants Emergency Use Authorization For First Point-Of-Care SARS-CoV-2 Antibody Test

Medscape (9/24, Brooks, Subscription Publication) reports the FDA “approved the first point-of-care (POC) antibody test for [SARS-CoV-2], under an emergency use authorization (EUA).” Back in July, the agency granted an EUA to Assure Tech’s Assure COVID-19...